Page 35 Cite

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2017. A Proposed Framework for Identifying Potential Biodefense Vulnerabilities Posed by Synthetic Biology: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/24832.

×

REFERENCES

Blight, K.J., A.A. Kolykhalov, and C.M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290(5498):1972-1974.

Blue Ribbon Study Panel on Biodefense. 2015. A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts. Available at: https://www.ecohealthalliance.org/wpcontent/uploads/2016/03/A-National-Blueprint-for-Biodefense-October-2015.pdf. Accessed on June 22, 2017.

Breaker, R. 2017. Presentation at the First Meeting for Committee on Strategies for Identifying and Addressing Biodefense Vulnerabilities Posed by Synthetic Biology, January 26, 2017, Washington, DC.

Brophy, J.A., and C.A. Voigt. 2014. Principles of genetic circuit design. Nature Methods 11(5):508-520.

Carter, S.R., and R.M. Friedman. 2015. DNA Synthesis and Biosecurity: Lessons Learned and Options for the Future. October 2015. Available at: http://www.jcvi.org/cms/fileadmin/site/research/projects/dnasynthesis-biosecurity-report/report-complete.pdf. Accessed on July 5, 2017.

CDC (U.S. Centers for Disease Control and Prevention). 2001. The Public Health Response to Biological and Chemical Terrorism: Interim Planning Guidance for State Public Health Officials. July 2001. Available at: https://emergency.cdc.gov/documents/planning/planningguidance.pdf. Accessed on May 12, 2017.

CDC. 2016. The Future of PulseNet. Available at: https://www.cdc.gov/pulsenet/next-generation.html. Accessed on May 12, 2017.

CDC. 2017. Preparation and Planning for Bioterrorism Emergencies. Available at: https://emergency.cdc.gov/bioterrorism/prep.asp. Accessed on May 12, 2017.

Cello, J., A.V. Paul, and E. Wimmer. 2002. Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science 297(5583):1016-1018.

Chen, T., N. Hongdilokkul, Z. Liu, D. Thirunavukarasu, and F.E. Romesberg. 2016. The expanding world of DNA and RNA. Current Opinion in Chemical Biology 34:80-87.

Clapper, J.E. 2016. Worldwide Threat Assessment of the U.S. Intelligence Community. Statement for the Record by James R. Clapper, Director of National Intelligence. Senate Armed Service Committee, February 16, 2016. Available at: https://www.dni.gov/files/documents/SASC_Unclassified_2016_ATA_SFR_FINAL.pdf. Accessed on May 19, 2017.

Cong, L., F.A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P.D. Hsu, X. Wu, W. Jiang, L.A. Marraffini, and F. Zhang. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819-823.

Cummings, C.L., and J. Kuzma. 2017. Societal Risk Evaluation Scheme (SRES): Scenario-based multi-criteria evaluation of synthetic biology applications. PLOS ONE 12(1):e0168564.

DHS (U.S. Department of Homeland Security). The BioWatch Program. Available at: https://www.dhs.gov/biowatch-program. Accessed on July 5, 2017.

DiEuliis, D., and J. Giordano. 2017. Why gene editors like CRISPR/Cas may be a game-changer for neuroweapons. Health Security 15(3):296-302.

Ejsmont, R.K., P. Ahlfeld, A. Pozniakovsky, A.F. Stewart, P. Tomancak, and M. Sarov. 2011. Recombination-mediated genetic engineering of large genomic DNA transgenes. Methods in Molecular Biology 772:445-458.

Elowitz, M.B., and S. Leibler. 2000. A synthetic oscillatory network of transcriptional regulators. Nature 403(6767):335-338.

Esvelt, K.M., A.L. Smidler, F. Catteruccia, and G.M. Church. 2014. Emerging technology: Concerning RNA-guided gene drives for the alternation of wild population. eLife 3:e03401.

Feldman, A.W., V.T. Dien, and F.E. Romesberg. 2017. Chemical stabilization of unnatural nucleotide triphosphates for the in vivo expansion of the genetic alphabet. Journal of the American Chemical Society 139(6):2464-2467.

Page 36 Cite

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2017. A Proposed Framework for Identifying Potential Biodefense Vulnerabilities Posed by Synthetic Biology: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/24832.

×

Fischbach, M., and C.A. Voigt. 2010. Prokaryotic gene clusters: A rich toolbox for synthetic biology. Biotechnology Journal 5(12):1277-1296.

Flamm, K. 2004. Moore’s Law and the economics of semiconductor price trends. Pp. 151-170 in Productivity and Cyclicality in Semiconductors: Trends, Implications, and Questions: Report of a Symposium. Washington, DC: The National Academies Press. Available at: https://www.nap.edu/read/11134/chapter/12. Accessed on May 12, 2017.

Gallagher, R.R., Z. Li, A.O. Lewis, and F.J. Isaacs. 2014. Rapid editing and evolution of bacterial genomes using libraries of synthetic DNA. Nature Protocols 9:2301-2316.

Gardner, T.S., C.R. Cantor, and J.J. Collins. 2000. Construction of a genetic toggle switch in Escherichia coli. Nature 403(6767):339-342.

Gibson, D.G., L. Young, R. Chuang, J.C. Venter, C.A. Hutchison, III, and H.O. Smith. 2009. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods 6:343-345.

Gibson, D.G., J.I. Glass, C. Lartigue, V.N. Noskov, R.Y. Chuang, M.A. Algire, G.A. Benders, M.G. Montague, L. Ma, M.M. Moodie, C. Merryman, S. Vashee, R. Krishnakumar, N. Assad-Garcia, C. AndrewsPfannkoch, E.A. Denisova, L. Young, Z.Q. Qi, T.H. Segall-Shapiro, C.H. Calvey, P.P. Parmar, C.A. Hutchison, III, H.O. Smith, and J.C. Venter. 2010. Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987):52-56.

Herfst, S., E.J.A. Schrauwen, M. Linster, S. Chutinimitkul, E. de Wit, V.J. Munster, E.M. Sorrell, T.M. Bestebroer, D.F. Burke, D.J. Smith, G.F. Rimmelzwaan, A.D. Osterhaus, and R.A. Fouchier. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088):1534-1541.

HHS (U.S. Department of Health and Human Services). 2013. Framework for Guiding Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza H5N1 Viruses That Are Transmissible Among Mammals by Respiratory Droplets. February 2013. Available at: https://www.phe.gov/s3/dualuse/Documents/funding-hpai-h5n1.pdf. Accessed on May 11, 2017.

HHS. 2010. Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA. Available at: https://www.phe.gov/Preparedness/legal/guidance/syndna/Pages/default.aspx. Accessed on May 22, 2017.

IAC/IAP (InterAcademy Council and The Global Network of Science Academies). 2012. Responsible Conduct in the Global Research Enterprise: A Policy Report. Available at: http://www.interacademies.net/File.aspx?id=19789. Accessed on July 5, 2017.

Imai, M., T. Watanabe, M. Hatta, S.C. Das, M. Ozawa, K. Shinya, G. Zhong, A. Hanson, H. Katsura, S. Watanabe, C. Li, E. Kawakami, S. Yamada, M. Kiso, Y. Suzuki, E.A. Maher, G. Neumann, and Y. Kawaoka. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403):420-428.

IOM/NRC (Institute of Medicine and National Research Council). 2006. Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: The National Academies Press.

JASON. 2005. Bioengineering. Available at: https://fas.org/irp/agency/dod/jason. Accessed on July 5, 2017.

JASON. 2007. Synthetic Viruses. Available at: https://fas.org/irp/agency/dod/jason. Accessed on July 5, 2017.

JASON. 2010. The $100 Genome: Implications for DoD. Available at: https://fas.org/irp/agency/dod/jason/hundred.pdf. Accessed on May 22, 2017.

Jefferson, C., F. Lentzos, and C. Marris. 2014. Synthetic biology and biosecurity: Challenging the “myths.” Frontiers in Public Health 2:Article 115.

Jinek, M., K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, and E. Charpentier. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816-821.

Jinek, M., A. East, A. Cheng, S. Lin, E. Ma, and J. Doudna. 2013. RNA-programmed genome editing in human cells. eLife 2:e00471.

Knight, T. 2003. Idempotent Vector Design for Standard Assembly of Biobricks. MIT Synthetic Biology Working Group Technical Reports. Available at: https://dspace.mit.edu/bitstream/handle/1721.1/21168/biobricks.pdf. Accessed on July 14, 2017.

Mali, P., L.H. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, and G.M. Church. 2013. RNA-guided human genome engineering via Cas9. Science 339(6121):823-826.

Page 37 Cite

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2017. A Proposed Framework for Identifying Potential Biodefense Vulnerabilities Posed by Synthetic Biology: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/24832.

×

Murphy, K.C., and K.G. Campellone. 2003. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Molecular Biology 4:11.

NASEM (National Academies of Sciences, Engineering, and Medicine). 2015. International Summit on Human Gene Editing, December 1-3, 2015, Washington DC.

NASEM. 2016. Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty, and Aligning Research with Public Values. Washington, DC: The National Academies Press.

Niu, Y.Y., B. Shen, Y.Q. Cui, Y.C. Chen, J.Y. Wang, L. Wang, Y. Kang, X.Y. Zhao, W. Si, W. Li, A.P. Xiang, J.K. Zhou, X.J. Guo, Y. Bi, C.Y. Si, B. Hu, G.Y. Dong, H. Wang, Z.M. Zhou, T.Q. Li, T. Tan, X.Q. Pu, F. Wang, S.H. Ji, Q. Zhou, X.X. Huang, W.Z. Ji, and J.H. Sha. 2014. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156(4):836-843.

NRC (National Research Council). 2004. Biotechnology Research in an Age of Terrorism. Washington, DC: The National Academies Press.

NSABB (National Science Advisory Board for Biosecurity). 2015. Framework for Conducting Risk and Benefit Assessments of Gain-of-Function Research. Available at: http://osp.od.nih.gov/sites/default/files/resources/NSABB_Framework_for_Risk_and_Benefit_Assessments_of_GOF_Research-APPROVED.pdf. Accessed on May 22, 2017.

NSABB. 2016. Recommendations for the Evaluation and Oversight of Proposed Gain-of-Function Research, May 24, 2016. Available at: http://osp.od.nih.gov/sites/default/files/resources/NSABB_Final_Report_Recommendations_Evaluation_Oversight_Proposed_Gain_of_Function_Research.pdf. Accessed on May 22, 2017.

Palumbo, R.N., and C. Wang. 2006. Bacterial invasin: Structure, function, and implication for targeted oral gene delivery. Current Drug Delivery 3(1):47-53.

Parts.igem.org. 2017. Registry of Standard Biological Parts. Available at: http://parts.igem.org/Main_Page. Accessed on May 19, 2017.

PCAST (President’s Council of Advisors on Science and Technology). 2016. Action Needed to Protect Against Biological Attack. November 2016. Available at: https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/PCAST/pcast_biodefense_letter_report_final.pdf. Accessed on May 11, 2017.

Petzold, C.J., L.J.G. Chan, M. Nhan, and P.D. Adams. 2015. Analytics for metabolic engineering. Frontiers in Bioengineering and Biotechnology 3:135.

Radosavljević, V., and B. Jakovljević. 2007. Bioterrorism—types of epidemics, new epidemiological paradigm and levels of prevention. Public Health 121(7):549-557.

Richardson, S.M., L.A. Mitchell, G. Stracquadanio, K. Yang, J.S. Dymond, J.E. DiCarlo, D. Lee, C.L.V. Huang, S. Chandrasegaran, Y. Cai, J.D. Boeke, and J.S. Bader. 2017. Design of a synthetic yeast genome. Science 355(6329):1040-1044.

Schmidt, M. 2010. Xenobiology: A new form of life as the ultimate biosafety tool. Bioessays 32(4):322-331.

Thodey, K., S. Galanie, and C.D. Smolke. 2014. A microbial biomanufacturing platform for natural and semisynthetic opioids. Nature Chemical Biology 10:837-844.

Tucker, J.B. 2012. Innovation, Dual Use, and Security: Managing the Risks of Emerging Biological and Chemical Technologies. Cambridge: The MIT Press.

Tumpey, T.M., C.F. Basler, P.V. Aguilar, H. Zeng, A. Solórzano, D.E. Swayne, N.J. Cox, J.M. Katz, J.K. Taubenberger, P. Palese, and A. Garcia-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310(5745):77-80.

U.S. Government. 2012. United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern. March 29, 2012. Available at: https://www.phe.gov/s3/dualuse/Documents/us-policy-durc032812.pdf. Accessed on May 11, 2017.

U.S. Government. 2014. United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern. September 24, 2014. Available at: https://www.phe.gov/s3/dualuse/Documents/durc-policy.pdf. Accessed on May 11, 2017.

Page 38 Cite

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2017. A Proposed Framework for Identifying Potential Biodefense Vulnerabilities Posed by Synthetic Biology: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/24832.

×

van Courtland Moon, J.E. 2006. The US biological weapons program. Pp. 9-46 in Deadly Cultures: Biological Weapons since 1945, M.L. Wheelis, L. Rózsa, and M.R. Dando, eds. Cambridge, MA: Harvard University Press.

Vogel, K.M. 2012. Phantom Menace or Looming Danger? A New Framework for Assessing Bioweapons Threats. Baltimore, MD: Johns Hopkins University Press.

Vogel, K.M. 2013. The need for greater multidisciplinary, sociotechnical analysis: The bioweapons case. Studies in Intelligence 57(3):1-10.

Voigt, C.A. 2012. Synthetic biology [editorial]. ACS Synthetic Biology 1:1-2.

White House. 2012. National Bioeconomy Blueprint. Available at: https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/national_bioeconomy_blueprint_april_2012.pdf. Accessed on June 22, 2017.

WHO (World Health Organization). 2016. An R&D Blueprint for Action to Prevent Epidemics. Available at: http://www.who.int/blueprint/about/r_d_blueprint_plan_of_action.pdf?ua=1. Accessed on June 22, 2017.

Wollert, T., B. Pasche, M. Rochon, S. Deppenmeier, J. van den Heuvel, A.D. Gruber, D.W. Heinz, A. Lengeling, and W. Schubert. 2007. Extending the host range of Listeria monocytogenes by rational protein design. Cell 129(5):891-902.

Yaung, S.J., C.M. Church, and H.H. Wang. 2014. Recent progress in engineering human-associated microbiomes. Methods in Molecular Biology 1151:3-25.